Form 4 · Filed May 27, 2026, 09:17 PM UTC
KRYS/Krystal Biotech, Inc.
Thomas John Charles — EVP, General Counsel
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
1 row| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 26, 2026 | S | sell | 642 | $302 | $193,903 | 0 |
Source: SEC EDGAR raw filing ↗ · Accession 0002114900-26-000006